!!Michal Novak  - Selected Publications
\\
1. Novak, P., Schmidt, R., Kontsekova, E., Zilka, N., Kovacech, B., Skrabana, R., Vince-Kazmerova, Z., Katina, S., Fialova, L., Prcina, M., Parrak, V., Dal-Bianco, P., Brunner, M., Staffen, W., Rainer, M., Ondrus, M., Ropele, S., Smisek, M., Sivak, R., Winblad, B., Novak, M. (2017) Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Neurology 16, 123-134.\\

2. Skrabana R, Kovacech B, Filipcik P, Zilka N, Jadhav S, Smolek T, Kontsekova E, Novak M. Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis. J Alzheimers Dis. 2017;58(4):1017-1025. doi: 10.3233/JAD-161124.\\

3. Paholikova, K., Salingova, B., Opattova, A., Skrabana, R., Majerova, P., Zilka, N., Kovacech, B., Zilkova, M., Barath, P., and Novak, M. (2015) N-terminal Truncation of Microtubule Associated Protein Tau Dysregulates its Cellular Localization, Journal of Alzheimers Disease 43, 915-926.\\

4. Filipcik, P., Cente, M., Zilka, N., Smolek, T., Hanes, J., Kucerak, J., Opattova, A., Kovacech, B., and Novak, M. (2015) Intraneuronal accumulation of misfolded tau protein induces overexpression of Hsp27 in activated astrocytes, Biochimica Et Biophysica Acta-Molecular Basis of Disease 1852, 1219-1229.\\

5. Zilka, N., Stozicka, Z., Cente, M., Kazmerova, Z., Kovacech, B., and Novak, M. (2012) Immunomodulation of Memory-Impairing Protein Tau in Alzheimer's Disease, Neurodegenerative Diseases 10, 242-245.\\

6. Zilka, N., Korenova, M., Kovacech, B., Iqbal, K., and Novak, M. (2010) CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy, Acta Neuropathologica 119, 679-687.\\

7. Zilka, N., Korenova, M., and Novak, M. (2009) Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies, Acta Neuropathologica 118, 71-86.\\

8. Novak, M., Kabat, J., and Wischik, C. M. (1993) Molecular characterization of the minimal protease resistant tau-unit of the Alzheimers-disease paired helical filament, Embo Journal 12, 365-370.\\

9. Novak, M., Jakes, R., Edwards, P. C., Milstein, C., and Wischik, C. M. (1991) DIFFERENCE BETWEEN THE TAU-PROTEIN OF ALZHEIMER PAIRED HELICAL FILAMENT CORE AND NORMAL TAU REVEALED BY EPITOPE ANALYSIS OF MONOCLONAL ANTIBODIES-423 AND ANTIBODIES-7.51, Proceedings of the National Academy of Sciences of the United States of America 88, 5837-5841.\\

10. Harrington, C. R., Mukaetovaladinska, E. B., Hills, R., Edwards, P. C., Degarcini, E. M., Novak, M., and Wischik, C. M. (1991) MEASUREMENT OF DISTINCT IMMUNOCHEMICAL PRESENTATIONS OF TAU-PROTEIN IN ALZHEIMER-DISEASE, Proceedings of the National Academy of Sciences of the United States of America 88, 5842-5846.\\
\\
Scientometric indicators (WOS, October 2018)\\
Number of full text publications  155\\
Number of  WOS entries 205\\
Total citations    6039 (5273 excluding autocitations)\\
Hirsch index        35